Allegion Stock Price, News & Analysis (NYSE:ALLE)

Allegion trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALLE."

Allegion declared a quarterly dividend on Thursday, September 5th. Shareholders of record on Monday, September 16th will be given a dividend of $0.27 per share on Monday, September 30th. This represents a $1.08 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date is Friday, September 13th. View Allegion's Dividend History.

Allegion PLC (NYSE:ALLE) issued its earnings results on Thursday, July, 25th. The scientific and technical instruments company reported $1.26 earnings per share for the quarter, missing the Zacks' consensus estimate of $1.31 by $0.05. The scientific and technical instruments company had revenue of $731.20 million for the quarter, compared to the consensus estimate of $750.76 million. Allegion had a net margin of 15.65% and a return on equity of 68.47%. Allegion's quarterly revenue was up 3.8% on a year-over-year basis. During the same period in the prior year, the firm posted $1.19 EPS. View Allegion's Earnings History.

Allegion is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Allegion.

Allegion will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Allegion updated its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share guidance of $4.80-4.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.86. The company issued revenue guidance of +4.5-5.5% yr/yr to ~$2.85-2.89 billion, compared to the consensus revenue estimate of $2.89 billion.

7 brokers have issued 12-month price targets for Allegion's shares. Their forecasts range from $92.00 to $116.00. On average, they expect Allegion's stock price to reach $107.71 in the next year. This suggests a possible upside of 2.5% from the stock's current price. View Analyst Price Targets for Allegion.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allegion in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allegion.

Media headlines about ALLE stock have been trending negative this week, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Allegion earned a daily sentiment score of -2.0 on InfoTrie's scale. They also assigned headlines about the scientific and technical instruments company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Allegion.

Allegion saw a decrease in short interest in the month of September. As of September 15th, there was short interest totalling 4,690,000 shares, a decrease of 6.0% from the August 15th total of 4,990,000 shares. Based on an average daily trading volume, of 674,600 shares, the days-to-cover ratio is presently 7.0 days. Approximately 5.1% of the shares of the stock are short sold. View Allegion's Current Options Chain.

Some companies that are related to Allegion include FANUC LTD JAPAN/ADR (FANUY), Roper Technologies (ROP), MURATA MFG CO L/ADR (MRAAY), Eaton (ETN), Johnson Controls International (JCI), Mitsui & Co Ltd (MITSY), Ingersoll-Rand (IR), Cintas (CTAS), ASSA ABLOY AB/S (ASAZY), Ball (BLL), Parker-Hannifin (PH), Stanley Black & Decker (SWK), Komatsu (KMTUY), SANDVIK AB/ADR (SDVKY) and Rockwell Automation (ROK).

Based on aggregate information from My MarketBeat watchlists, some companies that other Allegion investors own include General Electric (GE), AbbVie (ABBV), Citigroup (C), Nucor (NUE), Walmart (WMT), NVIDIA (NVDA), Abbott Laboratories (ABT), Pfizer (PFE), UnitedHealth Group (UNH) and FLIR Systems (FLIR).

Allegion's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Robeco Institutional Asset Management B.V. (0.83%), Handelsinvest Investeringsforvaltning (0.17%), Vigilant Capital Management LLC (0.17%), Envestnet Asset Management Inc. (0.08%), Calamos Advisors LLC (0.06%) and Nisa Investment Advisors LLC (0.04%). Company insiders that own Allegion stock include Chris E Muhlenkamp, Douglas P Ranck, Jeffrey M Wood, Jeffrey N Braun, Patrick S Shannon, Timothy P Eckersley and Tracy L Kemp. View Institutional Ownership Trends for Allegion.

ALLE stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Handelsinvest Investeringsforvaltning, Gateway Investment Advisers LLC, Robeco Institutional Asset Management B.V., Vigilant Capital Management LLC, State of Alaska Department of Revenue, Financial Gravity Wealth Inc. and Crossmark Global Holdings Inc.. Company insiders that have sold Allegion company stock in the last year include Chris E Muhlenkamp, Douglas P Ranck, Jeffrey M Wood, Jeffrey N Braun, Patrick S Shannon, Timothy P Eckersley and Tracy L Kemp. View Insider Buying and Selling for Allegion.

ALLE stock was purchased by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC, Calamos Advisors LLC, Wealthfront Advisers LLC, Sumitomo Mitsui DS Asset Management Company Ltd and Coastal Investment Advisors Inc.. View Insider Buying and Selling for Allegion.

Shares of ALLE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALLE stock can currently be purchased for approximately $105.13.

Allegion has a market capitalization of $9.82 billion and generates $2.73 billion in revenue each year. The scientific and technical instruments company earns $434.90 million in net income (profit) each year or $4.50 on an earnings per share basis. Allegion employs 11,000 workers across the globe.View Additional Information About Allegion.

The official website for Allegion is http://www.allegion.com/.

Allegion's mailing address is BLOCK D IVEAGH COURT HARCOURT ROAD, DUBLIN L2, 46032. The scientific and technical instruments company can be reached via phone at 353-1254-6200 or via email at [email protected]